Submitted by Anonymous (not verified) on 15 September 2023 - 8:18
Summary of opinion: Keytruda,pembrolizumab, 14/09/2023, Positive
Source:
Summary of opinion: Keytruda,pembrolizumab, 14/09/2023, Positive